Statins and the Urinary Proteome
NCT00464503 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 7
Last updated 2008-04-08
Summary
This study aims to investigate whether statines (rosuva- and pravastatin) induce tubular proteinuria.
Conditions
- Statin Induced Proteinuria
Interventions
- DRUG
-
Rosuvastatin-Crestor
- DRUG
-
Pravastatin-Pravasine
Sponsors & Collaborators
-
Universiteit Antwerpen
lead OTHER
Principal Investigators
-
Patrick C D'Haese, Prof · Universiteit Antwerpen
Study Design
- Allocation
- RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 25 Years
- Max Age
- 65 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2007-09-30
- Primary Completion
- 2007-10-31
- Completion
- 2007-10-31
Countries
- Belgium
Study Locations
More Related Trials
-
Intensive Statin Therapy in PCI Patient With Acute Coronary Syndrome
NCT01372839 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of Statins on Oxidative Stress and Endothelial Progenitor Cells
NCT00166036 ·Status: COMPLETED ·Phase: PHASE2
-
Statins for Prevention of Contrast Induced Nephropathy
NCT00770796 ·Status: COMPLETED ·Phase: PHASE4
-
The Effects of Pravastatin and Rosuvastatin on Coronary Plaques in Patients With Stable Angina Pectoris
NCT01325818 ·Status: UNKNOWN ·Phase: PHASE4
-
Assessment of the Effect of Atorvastatin on Prevention of CIN in Patients Undergoing Coronary Angiography
NCT02113540 ·Status: UNKNOWN ·Phase: PHASE3
-
Long-term Pleiotropic Effect of Statins in Patients With Peripheral Arterial Disease
NCT01041729 ·Status: COMPLETED ·Phase: PHASE4
-
Statin Treatment for UnruptureD Intracranial anEurysms Study
NCT04149483 ·Status: UNKNOWN ·Phase: PHASE2
-
Atorvastatin for Reduction of Myocardial Damage During Angiography and Its Mechanism Associated With IMR
NCT01761656 ·Status: UNKNOWN ·Phase: PHASE2
-
Protective Effect of Early High Dose stATins On Cardiovascular and Renal Events in Acute Coronary Syndrome
NCT04087200 ·Status: RECRUITING
-
Effect of Pitavastatin on Erythrocyte Membrane Fatty Acid Contents in Patients With Chronic Kidney Disease
NCT02863185 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Statin for Elderly Patients With Atherosclerotic Cardiovascular Disease
NCT04826354 ·Status: COMPLETED ·Phase: PHASE4
-
Effective Dose of Statin Post PCI
NCT04923152 ·Status: COMPLETED ·Phase: NA
-
Exercise-induced Muscle Damage in Statin Users
NCT05011643 ·Status: COMPLETED
-
Effect of Statins on Trained Immunity
NCT02817230 ·Status: COMPLETED
-
Atorvastatin Pre-Treatment Influences the Risk of Percutaneous Coronary Intervention (PCI) Study 2
NCT01058057 ·Status: UNKNOWN ·Phase: PHASE3
-
Short Term Statin Treatment and Endothelial Dysfunction Due to Ischemia and Reperfusion Injury
NCT00987974 ·Status: COMPLETED ·Phase: PHASE4
-
BIOchemical Urine Analysis of Adherence to Statins and Associated FACTorS in Coronary Artery Disease
NCT05814692 ·Status: UNKNOWN
-
Effects of Atorvastatin Versus Probucol on Small Dense LDL
NCT00276133 ·Status: COMPLETED ·Phase: PHASE4
-
High Dose Atorvastatin for Preventing Contrast-induced Nephropathy
NCT02114346 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Statin Use in Abdominal Aortic Aneurysm Repair
NCT01062802 ·Status: COMPLETED ·Phase: PHASE4
-
Using AtorVASTatin to Prevent VAscular Inflammatory OccLUSion in the Critically Ill
NCT01073800 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Early Therapeutic Effects of Statins and Fibrates on Unstable Atherosclerotic Plaques
NCT00243672 ·Status: WITHDRAWN ·Phase: PHASE4
-
Extended Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome
NCT01223586 ·Status: COMPLETED
-
Effectiveness of Creatine in Preventing Muscle Aching From Cholesterol-Lowering Statin Drugs
NCT00797407 ·Status: COMPLETED ·Phase: NA
-
Intensive Statin Treatment for STEMI Patients Undergoing Primary PCI
NCT01033058 ·Status: UNKNOWN ·Phase: PHASE4